In a workshop organized by the Clinical Research roundtable, representatives from purchaser organizations (employers), payer organizations (health plans and insurance companies), and other stakeholder organizations (voluntary health associations, clinical researchers, research organizations, and the technology community) came together to explore:
- What do purchasers and payers need from the Clinical Research Enterprise?
- How have current efforts in clinical research met their needs?
- What are purchasers, payers, and other stakeholders willing to contribute to the enterprise?
This book documents these discussions and summarizes what employers and insurers need from and are willing to contribute to clinical research from both a business and a national health care perspective.
- The Role of Purchasers and Payers in the Clinical Research Enterprise
- Copyright
- REVIEWERS
- Foreword
- Contents
- Workshop Summary
- Introduction to the Workshop
- 1 The Role of Purchasers in the Clinical Research Enterprise
- INTRODUCTION
- WHAT PURCHASERS NEED FROM THE CLINICAL RESEARCH ENTERPRISE
- PHARMACEUTICAL COSTS AND VALUE FOR PURCHASERS
- TRANSLATIONAL BLOCKS
- CHALLENGES FOR PURCHASERS IN THE CLINICAL RESEARCH ENTERPRISE
- PROPOSAL FOR A NATIONAL CLINICAL RESEARCH ENTERPRISE COORDINATING ACTIVITY
- Speaker Response to the Enterprise Coordinating Activity Proposal
- THE IMPORTANCE OF PREVENTION RESEARCH
- CONSUMER INVOLVEMENT
- PUBLICATION OF A RESEARCH PRIORITIES PROPOSAL
- SUMMARY
- 2 The Role of Payers in the Clinical Research Enterprise
- INTRODUCTION
- WHAT PAYERS NEED FROM THE CLINICAL RESEARCH ENTERPRISE
- WHAT PAYERS ARE WILLING TO CONTRIBUTE TO THE CLINICAL RESEARCH ENTERPRISE
- RESEARCH PRIORITIES AND PRIORITY SETTING FOR PAYERS
- TRANSLATIONAL BLOCKS
- CONSUMER DEMAND
- PATIENT PARTICIPATION IN CLINICAL RESEARCH
- SUMMARY
- 3 The Role of Other Stakeholders in the Clinical Research Enterprise
- INTRODUCTION
- THE ROLE OF VOLUNTARY HEALTH ASSOCIATIONS IN THECLINICAL RESEARCH ENTERPRISE
- PRIORITY SETTING IN BASIC AND CLINICAL RESEARCH
- PRIORITY SETTING IN HEALTH SERVICES RESEARCH
- HEALTH SERVICES RESEARCH INVOLUNTARY HEALTH ASSOCIATIONS
- THE ROLE OF THE DEVICE INDUSTRY IN THE CLINICAL RESEARCH ENTERPRISE
- THE ROLE OF THE AGENCY FOR HEALTH CARE RESEARCH AND QUALITY IN THE CLINICAL RESEARCH ENTERPRISE
- TRANSLATIONAL BLOCKS AND PRACTICE GUIDELINES
- SUMMARY
- 4 Opportunities and Challenges in the Clinical Research Enterprise
- INTRODUCTION
- OUTCOMES RESEARCH AND DISEASE MANAGEMENT
- INTEGRATED PATIENT-CENTERED CARE
- RESEARCH PRIORITIES IN PHARMACEUTICAL COMPANIES
- SUMMARY
- Suggested Readings
- Appendix I Speaker Biographies
- Appendix II Speaker’s Company Profiles
- AETNA
- AGENCY FOR HEALTHCARE RESEARCH AND QUALITY
- AMERICAN ASSOCIATION OF HEALTH PLANS
- AMERICAN CANCER SOCIETY
- AMERICAN DIABETES ASSOCIATION
- HEALTHPARTNERS
- MARRIOTT
- MEDICAL TECHNOLOGY LEADERSHIP FORUM
- UNITED HEALTHGROUP
- UNITED PARCEL SERVICE
- VERIZON
- WELLMARK
- Appendix III Purchaser Payer Background Information
- Appendix IV Workshop Agenda
- Appendix V Definitions of Clinical Research and Components of the Enterprise
- DEFINITION OF CLINICAL RESEARCH
- MAJOR COMPONENTS OF THE CLINICAL RESEARCH ENTERPRISE
- Sponsors
- Research Organizations
- Investigators
- Participants
- Oversight Entities
- Stakeholders/Consumers
- Appendix VI Registered Workshop Participants
Text
Audio
Adobe DRM
Login to your account